HEPA

Hepion Pharmaceuticals
HEPA

Delisted

HEPA was delisted on the 12th of May, 2025.

Back to rankings

4 hedge funds and large institutions have $99K invested in Hepion Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 2 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
4
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

1
-$38.7K
2
-$27K
3
-$19.4K
4
HighTower Advisors
HighTower Advisors
Illinois
-$19.4K
5
TSS
Two Sigma Securities
New York
-$7K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$23K
2
$23K
3
$19K
4
$14K
5
$5K
6
$4K
7
$4K
8
$3K
9
$1K
10
$1K
11
$1K
12
$1K
13
–
14
–
15
–